S5 Ep10: Dhakal Reflects on the FDA Approval of Cilta-Cel for Earlier Lines of RRMM

from Treating Together · host Targeted Oncology

In this episode of Targeted Talks, Binod Dhakal, MD, MS, discusses the recent FDA approval of ciltacabtagene autoleucel for the treatment of relapsed/refractory multiple myeloma.

Episode metadata supplied by the publisher feed · Published Jun 14, 2024

Embed this episode

Attribution link and audio player

Ready to play

S5 Ep10: Dhakal Reflects on the FDA Approval of Cilta-Cel for Earlier Lines of RRMM

0:00 20:11

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Treating Together?

This episode is 20 minutes long.

When was this Treating Together episode published?

This episode was published on June 14, 2024.

Can I download this Treating Together episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!